Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells

Oncogene volume 18, pages 2169–2180 (1999)Cite this article

Abstract

Our recent studies on the process of immortalization of cultured human mammary epithelial cells (HMEC) have uncovered a previously undescribed, apparently epigenetic step, termed conversion. When first isolated, clonally derived HMEC lines of indefinite lifespan showed little or no telomerase activity or ability to maintain growth in the presence of TGFβ. Cell populations whose mean terminal restriction fragment length had declined to <3 kb also exhibited slow heterogeneous growth, and contained many non-proliferative cells. With continued passage, these conditionally immortal cell populations very gradually converted to a fully immortal phenotype of good growth±TGFβ, expression of high levels of telomerase activity, and stabilization of telomere length. We now show that exposure of the early passage conditionally immortal 184A1 HMEC line to the viral oncogenes human papillomavirus type 16 (HPV16)-E6, -E7, or SV40T, results in either immediate (E6) or rapid (E7; SV40T) conversion of these telomerase negative, TGFβ sensitive conditionally immortal cells to the fully immortal phenotype. Unlike conditional immortal 184A1, the HPV16-E7 and SV40T exposed cells were able to maintain growth in TGFβ prior to expression of high levels of telomerase activity. A mutated HPV16-E6 oncogene, unable to inactivate p53, was still capable of rapidly converting conditional immortal 184A1. Our studies provide further evidence that the transforming potential of these viral oncogenes may involve activities beyond their inactivation of p53 and pRB functions. These additional activities may greatly accelerate a step in HMEC immortal transformation, conversion, that would be rate-limiting in the absence of viral oncogene exposure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB. . 1992 Proc. Natl. Acad. Sci. USA 89: 10114–10118.

  • Bacchetti S. . 1996 Cancer Surveys 28: 197–216.

  • Band V. . 1998 Int. J. Oncol. 12: 499–507.

  • Band V, De Caprio JA, Delmolino L, Kulsea V and Sager R. . 1991 J. Virol. 65: 6671–6676.

  • Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, Connolly J and Sager R. . 1990 Cancer Res. 50: 7351–7357.

  • Bartek J, Bartkova J, Kyprianou N, Lalani E-N, Staskova Z, Shearer M, Chang S and Taylor-Papadimitriou J. . 1991 Proc. Natl. Acad. Sci. USA 88: 3520–3524.

  • Belair CD, Lopez PM, Yeger TR and Reznikoff CA. . 1998 Proc. Natl. Acad. Sci. USA 94: 13677–13682.

  • Bodnar AG, Kim NW, Effros RB and Chiu C-P. . 1996 Exp. Cell Res. 228: 58–64.

  • Brenner AJ and Aldaz CM. . 1995 Cancer Res. 55: 2892–2895.

  • Brenner AJ, Stampfer MR and Aldaz CM. . 1998 Oncogene 17: 199–205.

  • Chiu C-P and Harley CB. . 1997 Proc. Soc. Exp. Biol. Med. 214: 99–106.

  • Choo CK, Rorke EA and Eckert RL. . 1993 Exp. Cell Res. 208: 161–169.

  • Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S. . 1992 EMBO J. 11: 1921–1929.

  • Counter CM, Botelho FM, Wang P, Harley CB and Bacchetti S. . 1994 J. Virol. 68: 3410–3414.

  • Dalal S, Gao Q, Androphy EJ and Band V. . 1996 J. Virol. 70: 683–688.

  • Ethier SP. . 1996 J. Mamm. Gland Bio. Neopl. 1: 111–121.

  • Finer MH, Dull TJ, Qin L, Farson D and Roberts MR. . 1994 Blood 83: 43–50.

  • Gollahon LS and Shay JW. . 1996 Oncogene 12: 715–725.

  • Hammond SL, Ham RG and Stampfer MR. . 1984 Proc. Natl. Acad. Sci. USA 81: 5435–5439.

  • Harris CC. . 1987 Cancer Res. 47: 1–10.

  • Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, De Vries EMG, Kovach JS and Sommer SS. . 1995 Oncogene 10: 681–688.

  • Holt SE, Wright WE and Shay JW. . 1997 Eur. J. Cancer 33: 761–767.

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW. . 1994 Science 266: 2011–2015.

  • Klingelhutz AJ, Barber SA, Smith PP, Dyer K and McDougall JK. . 1994 Mol. Cell Biol. 14: 961–969.

  • Klingelhutz AJ, Foster SA and McDougall JK. . 1996 Nature 380: 79–82.

  • Lee E-H, To H, Shew J-Y, Bookstein R, Scully P and Lee W-H. . 1988 Science 241: 218–221.

  • Lehman T, Modali R, Boukamp R, Stanek J, Bennett W, Welsh J, Metcalf R, Stampfer M, Fusenig N, Rogan E, Reddel R and Harris C. . 1993 Carcin. 14: 833–839.

  • Mal A, Poon RYC, Howe PH, Toyoshima H, Hunter T and Harter ML. . 1996 Nature 380: 262–265.

  • Mietz JA, Unger T, Huibregste JM and Howley P. . 1992 EMBO J. 11: 5013–5020.

  • Oren M, Maltman W and Levine AJ. . 1981 Mol. Cell Biol. 1: 101–110.

  • Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massagué J. . 1994 Cell 78: 59–66.

  • Renan MJ. . 1993 Mol. Carcin. 7: 139–146.

  • Sandhu C, Garbe J, Bhattacharya N, Daksis JI, Pan C-H, Yaswen P, Koh J, Slingerland JM and Stampfer MR. . 1997 Mol. Cell Biol. 17: 2458–2467.

  • Scheffner M, Huibregtse JM, Vierstra R and Howley PM. . 1993 Cell 75: 495–505.

  • Shay JW, Van Der Haegen BA, Ying Y and Wright WE. . 1993a Exp. Cell Res. 209: 45–52.

  • Shay JW, Wright WE, Brasiskyte D and Van Der Haegen BA. . 1993b Oncogene 8: 1407–1413.

  • Shay JW, Wright WE and Werbin H. . 1993c Breast Can. Res. Treat. 25: 83–94.

  • Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L and Bergh J. . 1996 J. Natl. Cancer Inst. 88: 173–182.

  • Stampfer M and Yaswen P. . 1994 Cancer Surveys 18: 7–34.

  • Stampfer MR. . 1982 In Vitro 18: 531–537.

  • Stampfer MR. . 1985 J. Tissue Culture Methods 9: 107–116.

  • Stampfer MR and Bartley JC. . 1985 Proc. Natl. Acad. Sci. USA 82: 2394–2398.

  • Stampfer MR and Bartley JC. . (1988). Human mammary epithelial cells in culture: differentiation and transformation In: Dickson R and Lippman M (eds). Breast Cancer: Cellular and Molecular Biology. Kluwer Academic Publishers: Norwell, Massachusetts. pp1–24.

    Google Scholar 

  • Stampfer MR, Bodnar A, Garbe J, Wong M, Pan A, Villeponteau B and Yaswen P. . 1997 Mol. Biol. Cell 8: 2391–2405.

  • Stampfer MR, Pan CH, Hosoda J, Bartholomew J, Mendelsohn J and Yaswen P. . 1993 Exp. Cell Res. 208: 175–188.

  • T'Ang A, Varley JM, Chakraborty S, Murphree AL and Fung Y-K. . 1988 Science 242: 263–266.

  • Thor AD, Moore DH, Edgerton SM, Kawasaki ES, Reihaus E, Lynch HT, Marcus JN, Schwartz L, Chen L-C, Mayall BH and Smith HS. . 1992 J. Natl. Cancer Inst. 84: 845–855.

  • Vaziri H and Benchimol S. . 1998 Curr. Biol. 8: 279–282.

  • Viallet J, Liu C, Emond J and Tsao M-S. . 1994 Exp. Cell Res. 212: 36–42.

  • Walen K and Stampfer MR. . 1989 Cancer Gen. Cyto. 37: 249–261.

  • Wazer DE, Liu X-L, Chu Q, Gao Q and Band V. . 1995 Proc. Natl. Acad. Sci. USA 92: 3687–3691.

  • Woodworth CD, Chung J, McMullin E, Plowman GD, Simpson S and Iglesias M. . 1996 Cell Growth Diff. 7: 811–820.

  • Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW and Jansen-Durr P. . 1996 Oncogene 13: 2323–2330.

Download references

Acknowledgements

We thank Vimla Band (Tufts University), Judy Campisi (LBNL), and Denise Galloway (U Washington) for providing viral constructs. This work was supported by NIH grant CA-24844 (MRS, PY), and the Office of Energy Research, Office of Health and Biological Research, US Department of Energy under Contract No. DE-AC03-76SF00098 (MRS, PY).

Author information

Authors and Affiliations

  1. Life Sciences Division, Lawrence Berkeley National Laboratory, Bldg, 934, Berkeley, 94720, California, USA

    James Garbe, Michelle Wong, Don Wigington, Paul Yaswen & Martha R Stampfer

Authors
  1. James Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Don Wigington
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Yaswen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martha R Stampfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garbe, J., Wong, M., Wigington, D. et al. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells. Oncogene 18, 2169–2180 (1999). https://doi.org/10.1038/sj.onc.1202523

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202523

Keywords

This article is cited by

Search

Advanced search

Quick links